CLINICAL DATA MANAGEMENT IMPORTANCE IN CLINICAL TRIALS

What is Clinical Data Management?


CDM also known as Clinical Trial Management System [CTMS] is the process of collection, cleaning, and operation of subject data in compliance with regulatory standards. The primary ideal of CDM processes is to give high-quality data by keeping the number of mistakes and missing data as low as possible and gathering maximum data for analysis. 

A CDMS or CTMS offers the following subsequent benefits

  • Construct trust with regulatory authorities

  • Records data remotely

  • Incorporate artificial intelligence

  • Balance threat reduction and lead time

  • Use module-based programming, which allows druggies more functionality

Crucial Members involved in CDM?


• Project Manager/ data manager

• Database administrator

• Database Programmer/ inventor

 • Clinical Data Associate


Why is CDM important in clinical trials?


Clinical research studies provide crucial information. Clinical data management provides:

  • Assurance of data quality Accelerated development

  • Protection from data loss

  • Reduced expenses

  • Security

  • Complete and accurate collection of data

  • A clean data set to support statistical analysis and reporting

  • A formatted data set for optimal and timely usability

  • Assurance of data integrity and quality throughout the data transfer


How is CDM used in clinical trials?


IMG_256


Stages of Clinical Data Management 


Clinical data Management consists of five stages, which gauge data collection, archiving, and presentation. The data administrator executes quality checks and data drawing throughout the workflow.



Challenges of using clinical Data Management in Clinical Trials


One of the biggest challenges in clinical data management faces is the sheer quantum of data that needs to be reused. With further and further patient data getting available, it can be difficult for CDM systems to keep up.

  1. Clinical trial complexity

The modern clinical trial design requires real-time data modeling and simulation to give reliable information that supports faster decision-making and reduces development time, costs, and late-stage disquisition failures. presently, multitudinous clinical trials are considered adaptive, meaning that they can change as the trial progresses and that incoming data is used to determine further upcoming steps. In such a scenario, if a case does not react to a drug, it may be decided to change the drug or dosage. 

 

  1. Mid Study changes

Clinical Data Management is a complex process. It involves multiple stakeholders, from investigators to Sponsors and CROs. This can make CDM grueling, especially when it comes to the mid-study changes (MSCs). Mid-study changes are amendments to protocols or study data management plans (SDMPs). 


What is the future of CDM?


The upcoming advancements in clinical data Management depend upon systems and regulations.

  • There must be clear policies regarding ownership of patient information and data sharing among organizations involved in a trial.

  •  Is likely to be more automated, with lesser use of artificial intelligence and machine literacy 

  • To shift through data to identify patterns and trends from spots, cases, and trials, which will help accelerate the medicine development process.

  •  These new technologies will lead to a better understanding of conditions and bettered patient issues to further ameliorate the accuracy and absoluteness of data.

In the future, CDMs may also need to be suitable to work with artificial intelligence and machine knowledge tools to help automate data operation tasks and meliorate data quality.


CONCLUSION


CDM has evolved in response to the ever-adding demand from pharmaceutical companies to Fast-track the drug development process and from the regulatory authorities to put quality systems in place to ensure the generation of high-quality data for accurate drug evaluation. To meet the prospects, there's a gradual shift from paper-based to electronic systems of data operation. In malignancy of these, CDM is evolving to come to a standard-based clinical research reality, by striking a balance between the prospects from and constraints in the being systems, driven by technological developments and business demands.






REFERENCES


  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326906/ 

  2. https://media.tghn.org/articles/QAWhat_is_clinical_data_management.pdf 

  3.  https://www.scilife.io/glossary/clinical-data-management 

  4. https://www.kenkyugroup.org/images/content/CCRRT-100103-F1.jpg

  5. https://www.scilife.io/glossary/clinical-data-management 

  6. https://www.clinion.com/insight/clinical-data-management-what-are-the-key-challenges/  

                                                                             

                       


Dr. Geethika Pravanya Alla

Pharm. D

ClinoSol id- 183/1022


Comments

Popular Posts